Pdt Partners, LLC Puma Biotechnology, Inc. Transaction History

Pdt Partners, LLC

$1 Billion
Q4 2024

A detailed history of Pdt Partners, LLC transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 11,131 shares of PBYI stock, worth $31,834. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,131

Previous 11,131 -0.0%

Holding current value

$31,834

Previous $28,000 17.86%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$2.92 - $5.83 $32,502 - $64,893	11,131 New	11,131 $36,000
Q1 2023 May 15, 2023	BUY	$2.21 - $4.82 $6,188 - $13,496	2,800 Added 14.62%	21,946 $67,000
Q4 2022 Feb 14, 2023	BUY	$2.12 - $5.08 $40,589 - $97,261	19,146 New	19,146 $80,000
Q2 2022 Aug 15, 2022	SELL	$1.64 - $3.3 $76,250 - $153,430	-46,494 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.13 - $3.24 $46,001 - $69,974	-21,597 Reduced 31.72%	46,494 $134,000
Q4 2021 Feb 14, 2022	BUY	$2.85 - $6.58 $3,884 - $8,968	1,363 Added 2.04%	68,091 $207,000
Q3 2021 Nov 15, 2021	BUY	$6.63 - $9.39 $4,017 - $5,690	606 Added 0.92%	66,728 $468,000
Q2 2021 Aug 16, 2021	SELL	$8.98 - $11.6 $51,482 - $66,502	-5,733 Reduced 7.98%	66,122 $607,000
Q1 2021 May 17, 2021	SELL	$9.38 - $13.63 $94,784 - $137,731	-10,105 Reduced 12.33%	71,855 $698,000
Q4 2020 Feb 16, 2021	SELL	$7.78 - $12.13 $360,665 - $562,322	-46,358 Reduced 36.13%	81,960 $841,000
Q3 2020 Nov 16, 2020	SELL	$9.5 - $11.14 $572,090 - $670,850	-60,220 Reduced 31.94%	128,318 $1.3 Million
Q2 2020 Aug 14, 2020	SELL	$7.01 - $13.24 $110,057 - $207,868	-15,700 Reduced 7.69%	188,538 $1.97 Million
Q1 2020 May 15, 2020	BUY	$6.28 - $14.57 $230,086 - $533,815	36,638 Added 21.86%	204,238 $1.72 Million
Q4 2019 Feb 14, 2020	SELL	$6.5 - $10.73 $538,258 - $888,540	-82,809 Reduced 33.07%	167,600 $1.47 Million
Q3 2019 Nov 14, 2019	BUY	$8.75 - $12.85 $548,703 - $805,810	62,709 Added 33.41%	250,409 $2.7 Million
Q2 2019 Aug 14, 2019	BUY	$12.3 - $35.76 $806,880 - $2.35 Million	65,600 Added 53.73%	187,700 $2.39 Million
Q1 2019 May 15, 2019	SELL	$20.77 - $42.37 $1,038 - $2,118	-50 Reduced 0.04%	122,100 $4.74 Million
Q4 2018 Feb 14, 2019	BUY	$20.07 - $46.7 $2.45 Million - $5.7 Million	122,150 New	122,150 $2.49 Million

Others Institutions Holding PBYI

# of Institutions

108

Shares Held

28.3M

Call Options Held

17.9K

Put Options Held

3.4K

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $130M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account